These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20105087)

  • 1. Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib.
    Bex A; Van der Veldt AA; Blank C; Meijerink MR; Boven E; Haanen JB
    Acta Oncol; 2010 May; 49(4):520-3. PubMed ID: 20105087
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus.
    Cost NG; Delacroix SE; Sleeper JP; Smith PJ; Youssef RF; Chapin BF; Karam JA; Culp S; Abel EJ; Brugarolas J; Raj GV; Sagalowsky AI; Wood CG; Margulis V
    Eur Urol; 2011 Jun; 59(6):912-8. PubMed ID: 21367518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted caval cytoreduction: solid foundations or shifting sands?
    Bex A; Clarke N
    Eur Urol; 2011 Jun; 59(6):919-20; discussion 921-2. PubMed ID: 21444147
    [No Abstract]   [Full Text] [Related]  

  • 4. [An image of vena cava thrombosis].
    Viguier JB; Amraoui S; Solanilla A; Boulon C; Constans J; Conri C
    J Mal Vasc; 2009 Nov; 34(5):372-3. PubMed ID: 19717254
    [No Abstract]   [Full Text] [Related]  

  • 5. Presurgical treatment with sunitinib for renal cell carcinoma with a level III/IV vena cava tumour thrombus.
    Horn T; Thalgott MK; Maurer T; Hauner K; Schulz S; Fingerle A; Retz M; Gschwend JE; Kübler HR
    Anticancer Res; 2012 May; 32(5):1729-35. PubMed ID: 22593453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of advanced renal cell carcinoma with inferior vena cava thrombus treated with sunitinib as neoadjuvant therapy].
    Chiba H; Hirose T; Shimoda N; Kanagawa K
    Nihon Hinyokika Gakkai Zasshi; 2012 Jul; 103(4):623-6. PubMed ID: 23120997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case records of the Massachusetts General Hospital. Case 17-2008. A 63-year-old man with metastatic renal-cell carcinoma.
    Michaelson MD; Iliopoulos O; McDermott DF; McGovern FJ; Harisinghani MG; Oliva E
    N Engl J Med; 2008 May; 358(22):2389-96. PubMed ID: 18509125
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neoadjuvant therapy for renal cancer].
    Thibault F; Rixe O; Meric JB; Renard-Penna R; Boostan H; Mozer P; Comperat E; Richard F; Bitker MO
    Prog Urol; 2008 Apr; 18(4):256-8. PubMed ID: 18501308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoluminal control of the inferior vena cava during resection of a level III tumor thrombus associated with renal cell carcinoma: a case report and review of the literature.
    Kanka KC; Tabibian L; Alexander J
    Vasc Endovascular Surg; 2010 Aug; 44(6):499-502. PubMed ID: 20519283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performing cytoreductive nephrectomy following targeted sunitinib therapy for metastatic renal cell carcinoma: a surgical perspective.
    Shaw GL; Hussain M; Nair R; Bycroft J; Beltran L; Green JS; Powles T; Peters JL
    Urol Int; 2012; 89(1):83-8. PubMed ID: 22614181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sunitinib as adjuvant therapy for renal cell carcinoma.
    Baker H
    Lancet Oncol; 2016 Nov; 17(11):e485. PubMed ID: 27773485
    [No Abstract]   [Full Text] [Related]  

  • 12. Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis.
    Field CA; Cotta BH; Jimenez J; Lane BR; Yim K; Lee HJ; Ryan ST; Hamilton ZA; Patel S; Wang S; Kane CJ; Dey S; Mckay RR; Noyes S; Millard FE; Rini BI; Campbell SC; Derweesh IH
    Clin Genitourin Cancer; 2019 Jun; 17(3):e505-e512. PubMed ID: 30808547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed tomography characteristics of unresectable primary renal cell carcinoma treated with neoadjuvant sunitinib.
    Salem ME; Shah SN; Elson P; Garcia JA; Wood LS; Medsinge A; Campbell S; Dreicer R; Rini BI
    Clin Genitourin Cancer; 2014 Apr; 12(2):117-23. PubMed ID: 24126239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dramatic reduction in tumor burden with neoadjuvant sunitinib prior to bilateral nephron-sparing surgery.
    Gorin MA; Ekwenna O; Soloway MS; Ciancio G
    Urology; 2012 Feb; 79(2):e11. PubMed ID: 21676439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case study of the month. Complete histologic remission after sunitinib neoadjuvant therapy in T3b renal cell carcinoma.
    Robert G; Gabbay G; Bram R; Wallerand H; Deminière C; Cornelis F; Bernhard JC; Ravaud A; Ballanger P
    Eur Urol; 2009 Jun; 55(6):1477-80. PubMed ID: 19150171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and histopathological effects of presurgical treatment with sunitinib for renal cell carcinoma with inferior vena cava tumor thrombus at a single institution.
    Ujike T; Uemura M; Kawashima A; Nagahara A; Fujita K; Miyagawa Y; Nonomura N
    Anticancer Drugs; 2016 Nov; 27(10):1038-43. PubMed ID: 27557138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A CASE OF RENAL CELL CARCINOMA WITH INFERIOR VENA CAVAL TUMOR THROMBUS WHICH THE REDUCTION OF TUMOR IN SPITE OF DRUG DISCONTINUANCE AFTER THE FULMINANT HEPATITIS ONSET WITH THE SUNITNIB].
    Shichijo T; Koizumi S; Ogawa Y; Matsubara E; Matsumoto Y; Saito K; Inoue K; Ogawa Y; Samejima M; Odagane T; Ishihara M; Higaki Y
    Nihon Hinyokika Gakkai Zasshi; 2018; 109(2):102-105. PubMed ID: 31006738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma.
    Thomas AA; Rini BI; Lane BR; Garcia J; Dreicer R; Klein EA; Novick AC; Campbell SC
    J Urol; 2009 Feb; 181(2):518-23; discussion 523. PubMed ID: 19100579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of recurrent intracaval renal cell carcinoma effectively treated with sunitinib].
    Komeya M; Matsumoto T; Fujinami K; Senga Y; Asakura T; Goto A
    Hinyokika Kiyo; 2010 Sep; 56(9):499-503. PubMed ID: 20940524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi.
    Karakiewicz PI; Suardi N; Jeldres C; Audet P; Ghosn P; Patard JJ; Perrotte P
    Eur Urol; 2008 Apr; 53(4):845-8. PubMed ID: 18053636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.